Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NATAMYCIN INDUSTRY
2.1 Summary about Natamycin Industry
2.2 Natamycin Market Trends
2.2.1 Natamycin Production & Consumption Trends
2.2.2 Natamycin Demand Structure Trends
2.3 Natamycin Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Natamycin 50%
4.2.2 Natamycin 95%
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Food Industry
4.3.2 Medical Industry
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Natamycin 50%
5.2.2 Natamycin 95%
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Food Industry
5.3.2 Medical Industry
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Natamycin 50%
6.2.2 Natamycin 95%
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Food Industry
6.3.2 Medical Industry
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Natamycin 50%
7.2.2 Natamycin 95%
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Food Industry
7.3.2 Medical Industry
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Natamycin 50%
8.2.2 Natamycin 95%
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Food Industry
8.3.2 Medical Industry
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Natamycin 50%
9.2.2 Natamycin 95%
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Food Industry
9.3.2 Medical Industry
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 DSM
10.1.2 DANISCO
10.1.3 Vgp Pharmachem
10.1.4 Handary
10.1.5 AMTECH Biotech
10.1.6 Zhejiang Silver Elephant Bio-engineering
10.1.7 Lanzhou Weiri Bio-engineering
10.1.8 MEIHUA Group
10.1.9 Zhengzhou New Frey Biotechnology
10.1.10 Chihon Biotechnology
10.1.11 Jiaozuo Joincare Biotechnological
10.1.12 Beijing Oriental Rada Biotech
10.1.13 Pucheng Lifecome Biochemistry
10.2 Natamycin Sales Date of Major Players (2017-2020e)
10.2.1 DSM
10.2.2 DANISCO
10.2.3 Vgp Pharmachem
10.2.4 Handary
10.2.5 AMTECH Biotech
10.2.6 Zhejiang Silver Elephant Bio-engineering
10.2.7 Lanzhou Weiri Bio-engineering
10.2.8 MEIHUA Group
10.2.9 Zhengzhou New Frey Biotechnology
10.2.10 Chihon Biotechnology
10.2.11 Jiaozuo Joincare Biotechnological
10.2.12 Beijing Oriental Rada Biotech
10.2.13 Pucheng Lifecome Biochemistry
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT